PubMed COVID-19 Clinical Care
18571 - 18580 of 51504 results found
Defining neutralization and allostery by antibodies against COVID-19 variants
Description
The changing landscape of SARS-CoV-2 Spike protein is linked to the emergence of variants, immune-escape and reduced efficacy of the existing repertoire of anti-viral antibodies. The functional activity of neutralizing antibodies is linked to their
Maternal mental health and impact on the newborn during the COVID-19 pandemic
Description
CONCLUSIONS: The pandemic negatively affected the mental health of mothers, posing significant challenges to promoting the emotional well-being of mothers and their infants.
Diverging humoral and cellular immune responses due to Omicron-a national study from the Faroe Islands
Description
Immunity following infection and vaccination with the SARS-CoV-2 Omicron variant is poorly understood. The aim was to investigate immunity assessed with antibody response, neutralizing antibodies (NAbs), and IFN-γ release under different scenarios
Women's experiences with solitary childbirth support in Ohio during COVID-19: Results from a qualitative study
Description
CONCLUSIONS: Women who gave birth in the first year of the COVID-19 pandemic and prior to the widespread availability of vaccines were particularly vulnerable to adverse perinatal outcomes, including stillbirth and postpartum depression
Knowledge of COVID-19 symptoms, transmission, and prevention: Evidence from health and demographic surveillance in Southern Mozambique
Description
Understanding community members' knowledge of SARS-CoV-2 transmission and prevention is essential for directing public health interventions to reduce disease spread and improve vaccination coverage. Here, we describe knowledge of COVID-19
Knowledge, attitudes and practices of French university students towards COVID-19 prevention-are health students better?
Description
During the COVID-19 outbreak in 2020, public health measures (PHM) were implemented to prevent the spread of SARS-CoV-2. At university, we wondered whether health students would be more likely to comply with these safety measures against infectious
Cost-Effectiveness of the Second COVID-19 Booster Vaccination in the USA
Description
CONCLUSION: The second booster strategy was likely to be dominant in reducing the disease burden of the COVID-19 pandemic. Expanding the second booster strategy to ages 18-49 and 12-17 years would remain dominant due to their social contacts with the
Childhood adversity and COVID-19 outcomes in the UK Biobank
Description
CONCLUSIONS: Childhood adversity was significantly associated with COVID-19-related hospitalisation and COVID-19-related mortality after adjusting for sociodemographic and health confounders. Further research is needed to clarify the biological and
